Clinical Research Directory
Browse clinical research sites, groups, and studies.
FMT for Alcohol Use Disorder in Cirrhotics.
Sponsor: Institute of Liver and Biliary Sciences, India
Summary
* Title "FMT for Alcohol Use Disorder in cirrhotics: A Randomized Controlled Trial" * The aim of the study is to study the efficacy of Fecal microbiota transplantation in patients with Alcohol liver disease over a 6 month duration without liver related side effects. The project will be conducted at ILBS over the period of 1 year. * The concept is to test the efficacy of FMT in alcohol related cirrhotics by its effect on achieving and maintaining abstinence and in reducing lapses and relapses. Thereby reducing the progression of alcoholic liver disease as continued ethanol consumption is an important predictor in increasing overall morbidity and mortality.
Official title: FMT for Alcohol Use Disorder in Cirrhotics: A Randomized Controlled Trial.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2024-07-27
Completion Date
2025-06-30
Last Updated
2024-07-30
Healthy Volunteers
No
Conditions
Interventions
FMT
\- Single dose (30gm/90ml) of FMT will be given via upper GI gastroduodenoscope at D4
SMT
Baclofen + AUD counselling
Placebo
Placebo identical to the FMT arm.
Locations (1)
Institute of Liver & Biliary Sciences (ILBS)
New Delhi, National Capital Territory of Delhi, India